Bioactive compounds: safety and efficacy
Hans-Konrad Biesalski1, Lars Ove Dragsted, Ibrahim Elmadfa
1Department of Biological Chemistry and Nutrition, University of Hohenheim, Stuttgart, Germany. biesal@uni-hohenheim.de
Abstract:
The efficacy and safety of bioactive compounds depend on a few known and unknown parameters. What is a physiologic dose and how can that dose be defined in cases of bioactive compounds with a poor knowledge of supply and distribution? What safety sets are needed? How can individual aspects such as polymorphisms or differences in absorption be considered? A group of experts tried to answer these and related questions during the 23rd Hohenheim Consensus Meeting at the University of Hohenheim in Stuttgart.
Related Concept Videos
Bioactivation and Tissue Toxicity
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Effects of Chemicals: Overview
Bioavailability: Overview
Bioavailability: Overview
Probiotics
